Press releases

• 17/06/2020 - (ITALIANO) PHARMANUTRA S.P.A.: COMUNICAZIONE AI SENSI DELL’ART. 17 DEL REGOLAMENTO EMITTENTI AIM ITALIA
• 12/06/2020 - AGREEMENT RELATED TO THE PATENT BOX REGIME SIGNED WITH THE REVENUE OFFICE
• 25/05/2020 - PHARMANUTRA S.P.A. TAKES PART IN THE AIM ITALIA CONFERENCE 2020
• 07/05/2020 - CETILAR® OBTAINS PLAY SURE DOPING FREE CERTIFICATION
• 29/04/2020 - PHARMANUTRA S.P.A.:NEW DISTRIBUTION AGREEMENTS IN EUROPE, ASIA AND LATIN AMERICA.
• 27/04/2020 - PHARMANUTRA S.P.A.: ORDINARY SHAREHOLDERS’ MEETING OF 27TH APRIL 2020
• 16/04/2020 - PRESENTATION OF PROPOSALS FOR APPOINTMENTS TO THE BOARD OF DIRECTORS OF PHARMANUTRA S.P.A.
• 15/04/2020 - PHARMANUTRA S.P.A.: PFIZER INVESTS IN SUCROSOMIAL® TECHNOLOGY
• 09/04/2020 - PHARMANUTRA S.P.A.: NOTICE OF CALL FOR ORDINARY SHAREHOLDERS’ MEETING
• 06/04/2020 - PHARMANUTRA S.P.A.: PROPOSAL TO AUTHORISE THE PURCHASE AND DISPOSAL OF TREASURY STOCK
• 03/04/2020 - PHARMANUTRA S.P.A.: FIGURES FOR THE FIRST QUARTER 2020 GROWING
• 25/03/2020 - PHARMANUTRA S.P.A. OBTAINS APPROVAL FOR TWO NEW PATENTS IN INDIA AND UNITED STATES
• 23/03/2020 - PHARMANUTRA S.P.A.: DOUBLE FIGURE GROWTH CONTINUES
• 23/03/2020 - (ITALIANO) PHARMANUTRA S.P.A.: COMUNICAZIONE AI SOCI IN MERITO AL DECRETO LEGGE “CURA ITALIA” EMANATO DAL GOVERNO
• 10/03/2020 - PHARMANUTRA S.P.A SUPPORTING THE NATIONAL HEALTH SERVICE IN THIS EMERGENCY
• 05/03/2020 - (ITALIANO) PHARMANUTRA S.P.A. LANCIA LA NUOVA CAMPAGNA MULTICANALE “FATTI TROVARE PRONTO” DEDICATA AD APPORTAL®.
• 07/02/2020 - NEW AGREEMENTS FOR THE DISTRIBUTION OF SIDERAL® IN MEXICO, THE CZECH REPUBLIC AND SLOVAKIA
• 03/02/2020 - PHARMANUTRA S.P.A.: CORPORATE EVENTS CALENDAR 2020
• 16/01/2020 - (ITALIANO) PHARMANUTRA S.P.A. PRESENTE ALLA SECONDA EDIZIONE DELL’“ITALIAN MID CAP CONFERENCE” DI MEDIOBANCA.
• 08/01/2020 - PHARMANUTRA S.P.A. ENGAGES MEDIOBANCA S.P.A. AS SPECIALIST
• 08/01/2020 - FOOD SUPPLEMENT MARKET IS GROWING IN ITALY AND SIDERAL® FORTE 20 CAPSULES IS THE MOST SOLD NUTRITIONAL SUPPLEMENT IN THE COUNTRY.
• 19/12/2019 - MEDIOBANCA – BANCA DI CREDITO FINANZIARIO S.P.A. STARTS SHARE COVERAGE
• 28/11/2019 - ONGOING INTERNATIONAL EXPANSION FOR THE GROUP, STRENGTHENED BY NEW PATENTS APPROVED
• 19/11/2019 - JUNIA PHARMA SRL LAUNCHES BLEFARENE BABY ON THE MARKET
• 12/11/2019 - PHARMANUTRA S.P.A. OBTAINS PATENT FOR A NEW COMPOSITION USED FOR TREATING CARDIOVASCULAR DISEASES
• 08/11/2019 - PHARMANUTRA WAS EXHIBITING AT CPHI WORLDWIDE 2019 IN FRANKFURT
• 05/11/2019 - PHARMANUTRA OBTAINS THE SOLID IRON PATENT FOR THE USA
• 22/10/2019 - PHARMANUTRA AT THE AIM ITALIA CONFERENCE DRIVEN BY THE POSITIVE ANALYST FORECASTS
• 17/09/2019 - PHARMANUTRA S.P.A.: RESULTS OF THE FIRST SEMESTER CONFIRM GROWTH IN DOUBLE FIGURES
• 10/09/2019 - PHARMANUTRA S.P.A. NEW AGREEMENT SIGNED WITH WERT PHILIPPINES FOR THE SIDERAL® RANGE
• 28/08/2019 - NEW AGREEMENT FOR THE DISTRIBUTION OF THE SIDERAL LINE IN TAIWAN
• 02/08/2019 - HISTORICAL MONTH-BASED SALES RECORD IN ITALY
• 29/07/2019 - ANTICIPATED INFORMATION ON THE PRELIMINARY CONSOLIDATED REVENUES OF THE FIRST HALF OF 2019
• 16/07/2019 - PHARMANUTRA S.P.A., RESULTS COME FROM RESEARCH
• 05/07/2019 - CETILAR® ONCE AGAIN THE MAIN SPONSOR OF PARMA CALCIO FOR THE 2019/2020 SEASON
• 12/06/2019 - PHARMANUTRA: SALES NETWORK EVOLUTION AND NEW COMMERCIAL STRATEGIES
• 05/06/2019 - THE INTERNATIONAL EXPANSION OF THE SIDERAL® LINE CONTINUES
• 29/05/2019 - NOTIFICATION PURSUANT TO ARTICLE 17 OF THE AIM ITALIA ISSUERS REGULATIONS
• 27/05/2019 - (ITALIANO) PHARMANUTRA PRESENTE ALL’AIM ITALIA CONFERENCE
• 10/05/2019 - CO-OPTATION OF A NEW ADMINISTRATOR
• 06/05/2019 - NEW INTERNATIONAL AGREEMENTS FOR THE CETILAR® LINE
• 23/04/2019 - JORDAN JOINS THE PHARMANUTRA PARTNER COUNTRIES
• 16/04/2019 - NOTIFICATION PURSUANT TO ARTICLE 17 OF THE AIM ITALIA ISSUERS REGULATIONS
• 16/04/2019 - NEW TRANSACTION BETWEEN SHAREHOLDERS
• 16/04/2019 - RESIGNATION OF A BOARD MEMBER
• 16/04/2019 - CLARIFICATION REGARDING THE 2018 DIVIDEND
• 16/04/2019 - SHAREHOLDERS' MEETING OF 15.04.2019
• 18/03/2019 - NEW INTERNATIONAL AGREEMENTS FOR THE DISTRIBUTION OF CETILAR® AND ULTRAMAG®
• 13/03/2019 - PHARMANUTRA DRAFT FINANCIAL STATEMENTS AND CONSOLIDATED FINANCIAL STATEMENTS AT 31.12.2018
• 12/03/2019 - THE 7TH EDITION OF THE INTERNATIONAL MULTIDISCIPLINARY COURSE ON IRON DEFICIENCY IN ROME
• 21/02/2019 - PHARMANUTRA SIGNS TWO NEW AGREEMENTS FOR THE DISTRIBUTION OF SUCROSOMIAL IRON IN GREECE AND UKRAINE
• 15/01/2019 - PHARMANUTRA SIGNS AN AGREEMENT WITH TRIGEN PHARMA INTERNATIONAL FOR THE DISTRIBUTION OF SIDERAL® PRODUCTS IN PAKISTAN
• 10/01/2019 - PHARMANUTRA: CORPORATE EVENTS CALENDAR 2019
• 20/12/2018 - PHARMANUTRA SIGNS AN IMPORTANT AGREEMENT TO DISTRIBUTE THE CETILAR® LINE IN THAILAND, OPENING UP THE SOUTH EAST ASIAN MARKET
• 14/12/2018 - AIM ITALY: PHARMANUTRA IN THE TOP 10 FOR PERFORMANCE AND CAPITALISATION
• 10/12/2018 - NEW AREAS OF APPLICATION RECOGNISED FOR SUCROSOMIAL IRON
• 04/12/2018 - PHARMANUTRA JOINS FARMINDUSTRIA
• 21/11/2018 - THE GROWTH TREND CONTINUES IN THE FIRST 9 MONTHS OF 2018: SALES ABROAD EXCEED SALES IN ITALY
• 05/11/2018 - FURTHER ACKNOWLEDGMENTS FOR SUCROSOMIAL IRON®
• 08/10/2018 - NEW RECOGNITIONS TO SUCROSOMIAL IRON®
• 04/10/2018 - NOTICE PURSUANT TO ARTICLE 17 OF AIM ITALIA ISSUER REGULATION
• 01/10/2018 - AN AGREEMENT HAS BEEN SIGNED WITH FRESENIUS KABI FOR THE DISTRIBUTION OF SUCROSOMIAL® IRON BASED PRODUCTS IN SWITZERLAND
• 26/09/2018 - PHARMANUTRA S.P.A.: THE RESULTS OF THE FIRST HALF CONFIRM A DOUBLE-DIGIT GROWTH
• 13/09/2018 - PHARMANUTRA GROUP LAUNCHES FOUR NEW PRODUCTS
• 30/08/2018 - PHARMANUTRA GROUP IS STILL GROWING ON THE ITALIAN MARKET
• 08/08/2018 - (ITALIANO) PHARMANUTRA CONFERMA LA TITLE SPONSORSHIP CON IL PARMA CALCIO 1913
• 26/07/2018 - PHARMANUTRA: REVENUES FOR THE FIRST HALF OF 2018 UP BY 20%. THE GROUP STRENGTHENS ITS INTERNATIONAL PRESENCE
• 18/07/2018 - PHARMANUTRA: GROWTH IN BUSINESS AND VALUE ONE YEAR FROM LISTING ON THE STOCK EXCHANGE
• 11/07/2018 - ULTRAMAG: SUCROSOMIAL TECHNOLOGY REVOLUTIONISES THE MAGNESIUM MARKET
• 05/07/2018 - PHARMANUTRA TAKES CENTRE STAGE AT THE “HEALTHCARE FORUM” AT THE BORSA ITALIANA
• 04/07/2018 - PHARMANUTRA PARTICIPATES IN THE "HEALTH CARE FORUM" IN BORSA ITALIANA
• 03/07/2018 - PHARMANUTRA: FRANCESCO SARTI APPOINTED CHIEF FINANCIAL OFFICER OF THE GROUP
• 28/06/2018 - PHARMANUTRA: NEW SALES RECORD IN MAY
• 28/05/2018 - NEW COMMERCIAL AGREEMENTS SIGNED FOR THE DISTRIBUTION OF SUCROSOMIAL® IRON ABROAD
• 23/04/2018 - PHARMANUTRA: SHAREHOLDERS' MEETING OF 23 APRIL 2018
• 11/04/2018 - 6TH INTERNATIONAL MULTIDISCIPLINARY COURSE ON IRON DEFICIENCY (IMCID)
• 06/04/2018 - PHARMANUTRA OBTAINS A PATENT FOR CETILAR® RM
• 27/03/2018 - PHARMANUTRA: SUCROSOMIAL® IRON CHOSEN AS PRODUCT OF THE YEAR BY ISRAELI CONSUMERS
• 20/03/2018 - PHARMANUTRA: THE BOARD OF DIRECTORS APPROVES THE DRAFT SEPARATE AND CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED 31 DECEMBER 2017
• 02/03/2018 - PHARMANUTRA: HIGHLY SUCCESSFUL FIRST EDITION OF THE CONVENTION DEDICATED TO INTERNATIONAL PARTNERS
• 22/02/2018 - PHARMANUTRA: 2017 PRELIMINARY RESULTS DOUBLE-DIGIT REVENUE AND MARGIN GROWTH
• 01/02/2018 - (ITALIANO) PHARMANUTRA: IN ARRIVO 4 NUOVI PRODOTTI SUL MERCATO
• 27/01/2018 - (ITALIANO) CALENDARIO DEGLI EVENTI SOCIETARI
• 18/10/2017 - COMMUNICATION OF CHANGING SOCIAL CAPITAL
• 30/09/2017 - COMUNICATO STAMPA - CONVERSIONE DELLE PRICE ADJUSTMENT SHARE
• 30/09/2017 - ESERCIZIO DEI WARRANT DI PHARMANUTRA S.P.A. PER IL PERIODO DAL 1 AL 29 SETTEMBRE 2017
• 18/09/2017 - PHARMANUTRA S.P.A. APPROVA LA RELAZIONE SEMESTRALE AL 30 GIUGNO 2017
• 11/09/2017 - PHARMANUTRA: CETILAR® DIVENTA MAIN SPONSOR DEL PARMA CALCIO 1913
• 31/08/2017 - ESERCIZIO DEI WARRANT DI PHARMANUTRA S.P.A. PER IL PERIODO DAL 1 AL 31 AGOSTO 2017
• 01/08/2017 - VERIFICATA LA CONDIZIONE DI ACCELERAZIONE DEI WARRANT PHARMANUTRA S.P.A.
• 01/08/2017 - COMUNICAZIONE DI ACCELERAZIONE WARRANT PHARMANUTRA S.P.A. IT0005274185
• 27/07/2017 - CALENDARIO DEGLI EVENTI SOCIETARI 2017
• 24/07/2017 - COMUNICAZIONE AI SENSI DELL’ART. 17 DEL REGOLAMENTO EMITTENTI AIM ITALIA
• 18/07/2017 - PRIMO GIORNO DI NEGOZIAZIONE DELLE AZIONI ORDINARIE E DEI WARRANT DI PHARMANUTRA S.P.A. SULL’AIM ITALIA
• 14/07/2017 - AMMISSIONE ALLE NEGOZIAZIONI DELLE AZIONI ORDINARIE E DEI WARRANT DI PHARMANUTRA S.P.A. SUL MERCATO AIM ITALIA